1 © Prescient & Strategic Intelligence Private Limited . All rights reserved Real World Evidence Solutions Market , Share, Growth, Development and Demand Forecast to 2030 2 © Prescient & Strategic Intelligence Private Limited . All rights reserved As per a report by P&S Intelligence, the real - world evidence solutions market generated revenue of USD 1,560 million in 2022, and it will witness a compound annual growth rate of 12.40%, to reach USD 3,974 million by 2030. The growth of the industry is due to the increasing number of clinical trials, rising research and developmen t activities for medical devices and drugs, and shifting focus from volume - based to value - based healthcare. Request for sample pages of this report: https://www.psmarketresearch.com/market - analysis/real - world - evidence - solutions - market/report - sample Furth ermore, RWE and RWD are used to advance protocol designs, with the aim of decreasing the number of expensive protocol revisions. These solutions can also be used in creating synthetic control arms, which will fasten trial execution and decrease the overall cost. Additionally, the rapid advancement in volume, generation speed, and variety of data and the necessity for quick insights are increasing the demand for the right technologies for RWE program implementation. Hence, numerous life science companies ar e implementing cloud technologies due to the speed, scalability, flexibility, and safety they offer. In 2022, the services category dominated the real - world evidence solutions market with a more than 56% share, and it will remain dominant throughout this decade. This is credited to the growing need for decrease in the delays in drug development and the availability of more healthcare information that needs to be analyzed. The data sets category is expected to grow at a significant rate in the near future. This is mainly because of the growing attention to gain more insights into epidemiology and the increasing amount of information generated in the healthcare sector. The pharmaceutical and medical device companies category will grow at the highest CAGR, o f 12.9%, in the years to come. This can be attributed to the need for the elimination of the costly drug recalls and drug performance evaluation in real - world settings and the increasing importance of real - world evidence (RWE) analyses in drug support. Ad ditionally, the pharmaceutical sector is increasingly using real - world evidence to meet the governing compliance necessities, along with the payer requirements related to health economics and outcomes research (HEOR). Browse full report at: https://www.ps marketresearch.com/market - analysis/real - world - evidence - solutions - market 3 © Prescient & Strategic Intelligence Private Limited . All rights reserved The APAC industry will grow at the highest CAGR, of approximately 14%, in the near future. The growth is mainly credited to the increasing incidence of chronic diseases, rising demand for advanced healthcare services, existence of various contract research organizations, growing number of clinical trials, strong support of governments for the adoption of RWE studies, and increasing elderly population. It is because of the increasing r esearch and development expenditure, rising demand for clinical and preclinical services during the drug development process, and increasing incidence of chronic diseases that the real - world evidence solution demand will considerably grow in the coming yea rs. Market Segmentation by Component Services Data Sets o Disparate Data Sets Clinical Settings Data Claims Data Pharmacy Data Patient - Powered Data Registry - Based Data Sets o Integrated Data Sets Market Segmentation by Application Drug Development and Approvals o Oncology o Neurology o Immunology o Cardiovascular Disease o Other Therapeutic Areas o Medical Device Development and Approvals Post - Market Surveillance Market Access Reimbursement/Coverage Decision Making Clinical And Regulatory Decision - Making Market Segmentation by End User Pharmaceutical & Medical Device Companies Healthcare Providers Healthcare Payers Other End Users 4 © Prescient & Strategic Intelligence Private Limited . All rights reserved Market Segmentation by Region North America Real World Evidence Solutions Market o By Component o By Application o By End User o By country – U.S. and Canada Europe Real World Evidence Solutions Market o By Component o By Application o By End User o By country – Germany, U.K., France, Italy, Spain, and Rest of Europe Asia - Pacific (APAC) Real World Evidence Solutions Market o By Component o By Application o By End User o By country – Japan, China, India, South Korea, Australia, and Rest of APAC Latin America (LATAM) Real World Evidence Solutions Market o By Component o By Application o By End User o By country – Brazil, Mexico and Rest of LATAM Middle East and Africa (ME A) Real World Evidence Solutions Market o By Component o By Application o By End User o By country – Saudi Arabia, South Africa, U.A.E., and Rest of MEA 5 © Prescient & Strategic Intelligence Private Limited . All rights reserved ©P&SIntelligence.Allrightsreserved 4 Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reprod uced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical - based media, magnetic, electronic, or digital, without a writte n permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B - 13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll - Free: 1 - 888 - 778 - 7886